# Point-Of-Care Virus Testing Co-Diagnostics Offers an Assay Development Strategy By Kalin Ned | Published 2026-05-25 | World Source: Trend Hunter, https://www.trendhunter.com/trends/codiagnostics References: [finance.yahoo](https://finance.yahoo.com/sectors/healthcare/articles/co-diagnostics-develops-ebola-assay-143419068.html)  Co-Diagnostics has completed an assay development strategy for the Bundibugyo virus, the strain of Ebola responsible for a recent outbreak in the Democratic Republic of the Congo and Uganda that led the [World Health Organization](https://www.trendhunter.com/trends/world-of-blue) to declare a public health emergency of international concern on May 17, 2026. Co-Diagnostics has stated it is prepared to rapidly make the test available on its Co Dx PCR point of care platform should the need arise. Additionally, the Co-Diagnostics platform's cloud-connected architecture also means that public health authorities could track cases in near real time, leading to more targeted containment measures — from localized travel advisories to hospital preparedness efforts. Even for someone who never contracts Ebola, the same platform and assay development approach could be adapted for other pathogens. Image Credit: Co-Diagnostics ## Trend Insights (Trend Hunter) - Score: 4.1/10 - Popularity: 22% | Activity: 24% | Freshness: 78% - Audience gender: 50% men, 50% women - Primary generations: Gen Z, Millennial, Gen X - Top markets: North America, Africa ## Categories [Trend Hunter](https://www.trendhunter.com/trends) > [World](https://www.trendhunter.com/world) > [Travel](https://www.trendhunter.com/travel) ## Key Themes ### What's Driving This Trend - **Rapid Point-of-care PCR:** Decentralized PCR devices capable of delivering lab-grade results at the bedside could shorten diagnostic timelines and shift testing away from centralized laboratories. - **Cloud-connected Disease Surveillance:** Near real-time case reporting via cloud-linked diagnostics may enable fine-grained public health visibility and predictive outbreak modeling. - **Modular Assay Development:** A platform approach that allows rapid assay adaptation for new pathogens could compress vaccine and therapeutic trial timelines by enabling faster case identification. ### Who This Affects Most - **Public Health and Epidemiology:** Integrated point-of-care testing with centralized data streams may transform outbreak response strategies and resource allocation at regional and national levels. - **Travel and Transportation:** Real-time diagnostic verification at transit hubs could redefine screening protocols and risk management for international travel networks. - **Hospital and Clinical Preparedness:** On-site rapid molecular diagnostics combined with predictive case data may reshape emergency department triage, isolation planning, and supply chain readiness. ## Related on Trend Hunter - [Portable Saliva Cancer Detectors](https://www.trendhunter.com/trends/AI-Enabled-Saliva-Device.md) - [Automated Molecular Diagnostic Systems](https://www.trendhunter.com/trends/genhome-array.md) - [Upgraded Molecular Testing Platforms](https://www.trendhunter.com/trends/molecular-testing-platform.md) - [Decentralized Diagnostic Testing](https://www.trendhunter.com/trends/BD-and-Babson-Diagnostics.md) - [Technologically Advanced Respiratory Tests](https://www.trendhunter.com/trends/respiratory-test.md) - [Automated Pcr Testing Systems](https://www.trendhunter.com/trends/automated-pcr-testing-system.md) - [Three-in-One At-Home Health Tests](https://www.trendhunter.com/trends/indicaid-covid19flu-ab-home-test.md) - [Avian Influenza Diagnostic Networks](https://www.trendhunter.com/trends/global-animal-health.md) - [On-Site Pathogen Detection Solutions](https://www.trendhunter.com/trends/onsite-pathogen-detection.md)